Status: Recruiting
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
Investigators will conduct the trial to determine whether paclitaxel and cisplatin (PT) has the same curative effects and less adverse effects than bleomycin, etoposide and cisplatin(BEP) among newly diagnosed malignant ovarian germ cell tumor patients after surgery.
Participants needed: 129
Trial details
Phase: Phase 3Age: 14-65Biological sex: FemaleType: InterventionalSponsor: Beihua KongUpdated: Apr 25, 2023Locations: 1
Eligibility criteria
Age≤65 years; female, Chinese women; [+13]
With severe or uncontrolled internal disease, unable to receive surgery and/or u... [+7]